Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Andrology

  Free Subscription


Articles published in Int J Clin Pract

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    October 2017
  1. LIVINGSTON M, Kalansooriya A, Hartland AJ, Ramachandran S, et al
    Serum testosterone levels in male hypogonadism: Why and when to check-A review.
    Int J Clin Pract. 2017 Oct 5. doi: 10.1111/ijcp.12995.
    PubMed     Text format     Abstract available


    September 2017
  2. KAMINETSKY JC, Stecher V, Tseng LJ
    Quality of erections by age group in men with erectile dysfunction.
    Int J Clin Pract. 2017 Sep 11. doi: 10.1111/ijcp.12976.
    PubMed     Text format     Abstract available


    May 2017
  3. CHO S, Kwon SS, Lee KW, Yoo TK, et al
    A multicenter real-life study of the efficacy of an alpha-blocker with or without anticholinergic agent (imidafenacin) treatment in patients with lower urinary tract symptoms/benign prostatic hyperplasia and storage symptoms.
    Int J Clin Pract. 2017;71.
    PubMed     Text format     Abstract available


    April 2017
  4. OHL DA, Stecher V, Tseng LJ
    Ethnicity and age as factors in sildenafil treatment of erectile dysfunction.
    Int J Clin Pract. 2017 Apr 24. doi: 10.1111/ijcp.12945.
    PubMed     Text format     Abstract available


    March 2017
  5. HACKETT G, Kirby M, Edwards D, Jones TH, et al
    UK policy statements on testosterone deficiency.
    Int J Clin Pract. 2017 Mar 20. doi: 10.1111/ijcp.12901.
    PubMed     Text format     Abstract available


  6. GOLDSTEIN I, Stecher V, Carlsson M
    Treatment response to sildenafil in men with erectile dysfunction relative to concomitant comorbidities and age.
    Int J Clin Pract. 2017;71.
    PubMed     Text format     Abstract available


    December 2016
  7. MULHALL JP, Luo X, Zou KH, Stecher V, et al
    Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA.
    Int J Clin Pract. 2016;70:1012-1018.
    PubMed     Text format     Abstract available


    October 2016
  8. ERTEL P, Adalig B, Demircan I, Lartey B, et al
    Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.
    Int J Clin Pract. 2016;70:870-880.
    PubMed     Text format     Abstract available


  9. MAGGI M, Wu FC, Jones TH, Jackson G, et al
    Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).
    Int J Clin Pract. 2016;70:843-852.
    PubMed     Text format     Abstract available


    August 2016
  10. CARBONE A, Fuschi A, Al Rawashdah SF, Al Salhi Y, et al
    Management of lower urinary tract symptoms associated with benign prostatic hyperplasia in elderly patients with a new diagnostic, therapeutic and care pathway.
    Int J Clin Pract. 2016 Aug 26. doi: 10.1111/ijcp.12849.
    PubMed     Text format     Abstract available


    July 2016
  11. RUSSO A, Capogrosso P, Ventimiglia E, La Croce G, et al
    Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review.
    Int J Clin Pract. 2016 Jul 25. doi: 10.1111/ijcp.12843.
    PubMed     Text format     Abstract available


    March 2016
  12. HACKETT G, Heald AH, Sinclair A, Jones PW, et al
    Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins.
    Int J Clin Pract. 2016;70:244-53.
    PubMed     Text format     Abstract available


    January 2016
  13. STEINKE E, Palm Johansen P, Fridlund B, Brostrom A, et al
    Determinants of sexual dysfunction and interventions for patients with obstructive sleep apnoea: a systematic review.
    Int J Clin Pract. 2016;70:5-19.
    PubMed     Text format     Abstract available


    August 2015
  14. VLACHOPOULOS C, Oelke M, Maggi M, Mulhall JP, et al
    Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia
    Int J Clin Pract. 2015 Aug 24. doi: 10.1111/ijcp.12722.
    PubMed     Text format     Abstract available


  15. WILLIAMS P, Bandhoo S, McBain H, Mulligan K, et al
    Erectile dysfunction and its detection in the healthcare setting: 10 years on.
    Int J Clin Pract. 2015;69:910-1.
    PubMed     Text format    


    July 2015
  16. EGAN KB, Suh M, Rosen RC, Burnett AL, et al
    Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008.
    Int J Clin Pract. 2015 Jul 28. doi: 10.1111/ijcp.12709.
    PubMed     Text format     Abstract available


  17. JIANN BP, Huang YJ
    Assessing satisfaction in men with premature ejaculation after dapoxetine treatment in real-world practice.
    Int J Clin Pract. 2015 Jul 21. doi: 10.1111/ijcp.12700.
    PubMed     Text format     Abstract available


    May 2015
  18. ILO D, Raluy-Callado M, Graham-Clarke P, Sadasivan R, et al
    Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational stu
    Int J Clin Pract. 2015 May 25. doi: 10.1111/ijcp.12657.
    PubMed     Text format     Abstract available


    October 2014
  19. HSU JC, Tang DH, Lu CY
    Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis.
    Int J Clin Pract. 2014 Oct 14. doi: 10.1111/ijcp.12548.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: